Garratt John W

SEC source: 0001225208-26-005672 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,897

F1 · kind: Acquisition of dividend equivalent rights on annual restricted stock unit awards.

SEC source: 0001225208-26-005187 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,741

F1 · kind: Grant of restricted stock units which become fully vested upon the earlier of (i) the first anniversary of the date of the grant of the award; or (ii) the date of the Company's 2027 annual meeting of stockholders, provided the reporting person remains in continuous service on the Board until such date, but the award may vest earlier in the event of death or disability. Should the reporting person terminate service for any other reason, a prorated number of the restricted stock units will vest.

SEC source: 0001225208-26-002394 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,247

F1 · kind: Acquisition of dividend equivalent rights on annual restricted stock unit awards.

SEC source: 0001646121-26-000003 · form4.xml · derivative · entry 2

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

SEC source: 0001646121-26-000003 · form4.xml · derivative · entry 3

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18

Underlying: Humana Common · 16 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

SEC source: 0001225208-25-009525 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,144

F1 · kind: Acquisition of dividend equivalent rights on annual restricted stock unit awards.

SEC source: 0001646121-25-000005 · primarydocument.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,933

F1 · shares: Represents an annual award of time-based RSUs payable to independent directors pursuant to the Company's 2020 Omnibus Incentive Compensation Plan. Award will cliff vest on November 20, 2026.

SEC source: 0001225208-25-007616 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,069

F1 · kind: Acquisition of dividend equivalent rights on annual restricted stock unit awards.

SEC source: 0001225208-25-005648 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,004

F1 · kind: Acquisition of dividend equivalent rights on annual restricted stock unit awards.

SEC source: 0001225208-25-005043 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,935

F1 · kind: Grant of restricted stock units which become fully vested upon the earlier of (i) the first anniversary of the date of the grant of the award; or (ii) the date of the Company's 2026 annual meeting of stockholders, provided the reporting person remains in continuous service on the Board until such date, but the award may vest earlier in the event of death or disability. Should the reporting person terminate service for any other reason, a prorated number of the restricted stock units will vest.

SEC source: 0001225208-25-002312 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,646

F1 · kind: Acquisition of dividend equivalent rights on annual restricted stock unit awards.

SEC source: 0001062993-25-000054 · form4.xml · derivative · entry 2

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,163

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

SEC source: 0001225208-24-010338 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,612

F1 · kind: Acquisition of dividend equivalent rights on annual restricted stock unit awards.

SEC source: 0001562180-24-007953 · primarydocument.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,543

F1 · shares: Represents an annual award of time-based RSUs payable to independent directors pursuant to the Company's 2020 Omnibus Incentive Compensation Plan. Award will cliff vest on November 21, 2025.

SEC source: 0001225208-24-008440 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,580

F1 · kind: Acquisition of dividend equivalent rights on annual restricted stock unit awards.

SEC source: 0001225208-24-006596 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,546

F1 · kind: Acquisition of dividend equivalent rights on restricted stock units awarded November 6, 2023, and May 13, 2024.

SEC source: 0001225208-24-006020 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,512

F1 · kind: Grant of restricted stock units which become fully vested upon the earlier of (i) the first anniversary of the date of the grant of the award; or (ii) the date of the Company's 2025 annual meeting of stockholders, provided the reporting person remains in continuous service on the Board until such date, but the award may vest earlier in the event of death or disability. Should the reporting person terminate service for any other reason, a prorated number of the restricted stock units will vest.

SEC source: 0001225208-24-003109 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 929

F1 · kind: Acquisition of dividend equivalent rights on restricted stock units awarded November 6, 2023.

SEC source: 0001062993-24-000120 · form4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,685

F3 · balance_after: Includes 430 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2024.

SEC source: 0001062993-24-000120 · form4.xml · derivative · entry 3

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2

Underlying: Humana Common · 2 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

SEC source: 0001562180-23-008504 · primarydocument.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,605

F1 · shares: Represents a pro rata equity award of 1,605 restricted shares under the Company's Omnibus Incentive Compensation Plan in connection with the reporting person's partial year of service as a director since first being appointed to the Board of Directors on December 19, 2023. The shares will vest on November 16, 2024.

SEC source: 0001225208-23-010481 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 924

F1 · kind: Acquisition of dividend equivalent rights on restricted stock units awarded November 6, 2023.

SEC source: 0001225208-23-010111 · doc4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 918

F1 · kind: Grant of restricted stock units which become fully vested upon the earlier of (i) the first anniversary of the date of the grant of the award; or (ii) the date of the Company's 2024 annual meeting of stockholders, provided the reporting person remains in continuous service on the Board until such date, but the award may vest earlier in the event of death or disability. Should the reporting person terminate service for any other reason, a proratednumber of the restricted stock units will vest.

SEC source: 0001062993-23-008438 · form4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,151

F1 · shares: Shares of common stock surrendered to the Issuer in payment of taxes in connection with the vesting and payment of a portion of performance share units ("PSUs") granted March 17, 2020 (997 shares from the vesting of PSUs earned as a result of the Issuer's fiscal year 2020 adjusted EBITDA performance and 2,909 shares from the vesting of PSUs earned as a result of the Issuer's fiscal years 2020-2022 adjusted ROIC performance), March 16, 2021 (551 shares from the vesting of PSUs earned as a result of the Issuer's fiscal year 2021 adjusted EBITDA performance) and March 15, 2022 (497 shares from the vesting of PSUs earned as a result of the Issuer's fiscal year 2022 adjusted EBITDA performance).

SEC source: 0001062993-23-007034 · form4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,105

F1 · shares: Performance share units ("PSUs") earned from March 17, 2020 & March 15, 2022 grants, as certified by Issuer's Compensation Committee on March 14, 2023. Each PSU represents right to one share of Issuer's common stock. Amount reported includes: (i) 7,599 PSUs earned as a result of Issuer's fiscal years 2020-2022 average adjusted ROIC performance, all of which will become vested & be settled & paid in unrestricted shares of Issuer's common stock on April 1, 2023; and (ii) 3,779 PSUs earned as a result of Issuer's fiscal year 2022 adjusted EBITDA performance, 1,261 of which will become vested & be settled & paid in unrestricted shares of Issuer's common stock on April 1, 2023, & remainder of which is subject to time-vesting requirements (1,259 on each of April 1, 2024 and April 1, 2025) & certain forfeiture & accelerated vesting provisions.

SEC source: 0001062993-23-000414 · form4.xml · derivative · entry 2

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380

Underlying: Humana Common · 380 shares

Expires not disclosed

F1 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023.

SEC source: 0001062993-22-023090 · form4.xml · derivative · entry 1

Garratt John W · CIK 0001646121 · President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,696

Underlying: Common Stock · 4,696 shares

Expires 2032-11-29

F1 · derivative.exercise_date: The option vests in four annual installments of 25% beginning on November 29, 2023, subject to certain forfeiture and accelerated vesting provisions.

SEC source: 0001062993-22-018878 · form4.xml · derivative · entry 5

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,877 shares

Expires 2028-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-22-018878 · form4.xml · nonDerivative · entry 4

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,727

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $238.00 to $238.505, inclusive. The reporting person undertakes to provide Dollar General Corporation, any security holder of Dollar General Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001062993-22-018878 · form4.xml · nonDerivative · entry 3

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,604

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-22-018878 · form4.xml · nonDerivative · entry 2

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,727

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $238.00 to $238.105, inclusive. The reporting person undertakes to provide Dollar General Corporation, any security holder of Dollar General Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001062993-22-018878 · form4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,420

F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $244.90 to $244.96, inclusive. The reporting person undertakes to provide Dollar General Corporation, any security holder of Dollar General Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001062993-22-009712 · form4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,227

F1 · shares: Shares of common stock surrendered to the Issuer in payment of taxes in connection with the vesting and payment of a portion of performance share units ("PSUs") granted March 20, 2019 (468 shares from the vesting of PSUs earned as a result of the Issuer's fiscal year 2019 adjusted EBITDA performance and 3,399 shares from the vesting of PSUs earned as a result of the Issuer's fiscal years 2019-2021 adjusted ROIC performance), March 17, 2020 (997 shares from the vesting of PSUs earned as a result of the Issuer's fiscal year 2020 adjusted EBITDA performance) and March 16, 2021 (552 shares from the vesting of PSUs earned as a result of the Issuer's fiscal year 2021 adjusted EBITDA performance).

SEC source: 0001062993-22-007925 · form4.xml · derivative · entry 1

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,458

Underlying: Common Stock · 23,458 shares

Expires 2032-03-15

F1 · derivative.exercise_date: The option vests in four annual installments of 25% beginning on April 1, 2023, subject to certain forfeiture and accelerated vesting provisions.

SEC source: 0001062993-22-007285 · form4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,643

F1 · shares: Performance share units ("PSUs") earned from March 20, 2019 & March 16, 2021 grants, as certified by Issuer's Compensation Committee on March 8, 2022. Each PSU represents right to one share of Issuer's common stock. Amount reported includes: (i) 8,637 PSUs earned as a result of Issuer's fiscal years 2019-2021 average adjusted ROIC performance, all of which will become vested & be settled & paid in unrestricted shares of Issuer's common stock on April 1, 2022; and (ii) 4,199 PSUs earned as a result of Issuer's fiscal year 2021 adjusted EBITDA performance, 1,401 of which will become vested & be settled & paid in unrestricted shares of Issuer's common stock on April 1, 2022, & remainder of which is subject to time-vesting requirements (1,399 on each of April 1, 2023 and April 1, 2024) & certain forfeiture & accelerated vesting provisions.

SEC source: 0001062993-22-000504 · form4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,255

F1 · balance_after: Includes 412 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/22.

SEC source: 0001062993-21-012327 · form4.xml · derivative · entry 8

Garratt John W · CIK 0001646121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,829

Underlying: Common Stock · 5,944 shares

Expires 2030-03-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · balance_after: The number of securities reported in the third row of Column 9 represents 5,943 options that are scheduled to vest on each of April 1, 2022, April 1, 2023, and April 1, 2024.

SEC source: 0001062993-21-012327 · form4.xml · derivative · entry 7

Garratt John W · CIK 0001646121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,832

Underlying: Common Stock · 10,835 shares

Expires 2029-03-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested as to 5,419 shares on April 1, 2020 and as to 5,416 shares on April 1, 2021.

F6 · balance_after: The number of securities reported in the second row of Column 9 represents 5,416 options that are scheduled to vest on each of April 1, 2022 and April 1, 2023.

SEC source: 0001062993-21-012327 · form4.xml · derivative · entry 6

Garratt John W · CIK 0001646121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,877

Underlying: Common Stock · 12,633 shares

Expires 2028-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 5,756 shares on April 1, 2020 and as to 6,877 shares on April 1, 2021.

F4 · balance_after: The number of securities reported in the first row of Column 9 represents 6,877 options that are scheduled to vest on April 1, 2022.

SEC source: 0001062993-21-012327 · form4.xml · nonDerivative · entry 5

Garratt John W · CIK 0001646121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,807

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $223.59 to $223.98, inclusive. The reporting person undertakes to provide Dollar General Corporation, any security holder of Dollar General Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001062993-21-012327 · form4.xml · nonDerivative · entry 4

Garratt John W · CIK 0001646121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,107

F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $222.58 to $223.575, inclusive. The reporting person undertakes to provide Dollar General Corporation, any security holder of Dollar General Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001062993-21-012327 · form4.xml · nonDerivative · entry 3

Garratt John W · CIK 0001646121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-21-012327 · form4.xml · nonDerivative · entry 2

Garratt John W · CIK 0001646121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,275

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-21-012327 · form4.xml · nonDerivative · entry 1

Garratt John W · CIK 0001646121 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,440

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000029534-21-000052 · edgar.xml · derivative · entry 7

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,510

Underlying: Common Stock · 8,000 shares

Expires 2028-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 6,879 shares on April 1, 2019 and 1,121 shares on April 1, 2020.

F4 · balance_after: The number of securities in Row 3 of Column 9 represents 5,756 options vested on April 1, 2020, 6,877 options vested on April 1, 2021, and 6,877 options scheduled to vest on April 1, 2022.

SEC source: 0000029534-21-000052 · edgar.xml · derivative · entry 6

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,421 shares

Expires 2027-03-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000029534-21-000052 · edgar.xml · derivative · entry 5

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,890 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 4,668 shares on April 1, 2019 and 8,222 shares on April 1, 2020.

SEC source: 0000029534-21-000052 · edgar.xml · nonDerivative · entry 4

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,807

F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $205.00 to $205.25, inclusive. The reporting person undertakes to provide Dollar General Corporation, any security holder of Dollar General Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0000029534-21-000052 · edgar.xml · nonDerivative · entry 3

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000029534-21-000052 · edgar.xml · nonDerivative · entry 2

Garratt John W · CIK 0001646121 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.